Skip navigation

Genesis 2011 Speaker Presentations

Speaker's Name

Company

Title of talk

Presentation

Ajay

Mistry

Polytherics

The future of therapy is Proteins

Click Here

Chris Ullman    

Isogenica

The future of therapy is Peptides 

Click Here

 

 

Clive Page    

Verona Pharma

Pipelines of the future -Expectations that biotechs/

academia/

NIH/CRUK will supply it all currently unreasonable

Click Here

Cyril Clarke

ICON Development Solutions 

Forcing Failure - Is it too negative a Mind-Set for your Development Programme?

Click Here

David Maughan

MESM Ltd 

Outsourcing of equipment. Automotive Vs Pharmaceutical

Click Here

Deborah Cockerill    

SCIAD

The Science of Online Communications

Click Here

L. Denzil Phillips

Denzil Phillips International, UK

Unlocking the health potential of African medical plants

Click Here

Edward Agne

Communication Strategy Group

Managing, the Good, the Bad and the Ugly of News flow 

Click Here

Ewan Campbell     

The Clinical Trial Company

The New Paradigm for Clinical Trial Outsourcing by Virtual Biotech Companies

Click Here

Ewan Phillips 

Deltex Medical

From shed to shedloads - Funding innovation medtech over the long haul

Click Here

Flic Gabbay    

TranScrip Partners

A paradigm shift in drug development 

Click Here

 

 

Graham Hughes

Elleray Scientific 

Supporting the future - Overview of the service sector and how it is changing 

Click Here

Greer Deal    

Global Regulatory Service (GRS)

Regulations: compliance and enforcement - the reality

Click Here

Ian Scouler    

Phynova Group Ltd

East meets West with novel botanicals 

Click Here

John Ansell

John Ansell Consultancy

Licensing the future - An Overview

Click Here 

Jon

Wood

 

 

 

Syne qua non

Functional Outsourcing as a Strategy for Clinical development - don't put all your eggs in one basket 

      Click Here        



 

 

 

 

 

 

 

Joseph Wildy

BIA 

The BIA engagement with policymakers 

Click Here

Malcolm Young

e-Therapeutics

 

Discovery for the future- Small pharma thinking

Click Here

Mike Ward

Scrip Intelligence

The Scrip guide to the winners and the losers of 2011

Click Here

 

 

Mike Romanos

 

Cresecendo 

Single domain antibody therapeutics from an in vivo platform 

Click Here 

Nathan Nagel

Oncology Pharma 

Using Social Media for Strategic Newsflow 

Click Here

Peter Brenders

 

BIOTECanada 

A neighbour's view of change in the US Life Science and Healthcare market 

Click Here 

 Ray Cooper

Phytoscience LLC and Hong Kong Polytechnic 

University 

Cracked eggs and tea: Linking veterinary and human health 

Click Here

 

Richard Jones

Shield Therapeutics 

Funding the future - an overview 

Click Here 

 

Rick Cousins 

Glaxo SmithKline Plc

Discovery for the future – Big pharma thinking

Click Here

 

 

Robert Nash

Phytoquest Ltd, UK

Novel Plant water-soluble components for food/cosmetic ingredients and pharma use

Click Here

 

Rowan Gardner

Biolauncher

Financing valuation in medical devices

Click Here

Stuart Barr

HighQ Solutions

Making the world a smaller place when it comes to enabling enterprise collaboration

Click Here

Thomas Warthoe

Atonomics

How to manage and maintain a successful relationship to strategic investors

Click Here

Trevor Perrior

Domainex

The future of Therapy is None of the above

Click Here

Will Spooner

Eagle Genomics Ltd, UK

How genomics, NGS, and cloud computing can enhance phytomedicine in early stage research and development

Click Here